PPT-Public Health Approach to Cannabis Regulation

Dr Robert Strang CMOH Nova Scotia Department of Health and Wellness Cannabis use lifetime and past year by province 2013 Health Canada 2014 Last 12 month use of cannabis by province grades . Dr. Bareket Schiff Keren. Some history. GLOBAL. AND. LOCAL. Gan. -. zi. -gun-nu. – the drug that takes away the mind. Azallu. . – hand of ghost, poison of all limbs. (neurological diseases?). U.S. Federal Patent. http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6630507.PN.&OS=PN/6630507&RS=PN/6630507. By: Phyliss Nicole Taylor, MD . Medical Director, Assistant Professor . UF Health Psychiatry . Financial Disclosures . None . Objectives. Understand what Amendment 2 means for FL physicians and patients. . drug control . system and its effects on science. Tom Blickman– TNI. tblick@tni.org. The Rise and Decline of Cannabis Prohibition. The . History of Cannabis in the UN Drug Control System and Options For Reform. IWK Health Centre, Halifax, Nova Scotia. CSAM-SCAM Fundamentals. DISCLOSURE. No conflict of interest to declare. No pharmaceutical industry support. No support from cannabis producers. Fundamentals: Cannabis Dependence. The Cole Memo – August 2013. Distribution to minors. Revenue going to criminals. Going to states where it is not legal. Used as a cover for trafficking of other illegal drugs/activity. Violence and use of guns in cultivation and distribution. Victoria. Dr. Daniel Perkins. Manager Research Strategy and Policy. Office of Medicinal Cannabis. Department of Health and Human Services Victoria. Cannabis regulatory framework. Victorian reform. December . Dra. Leticia Cuñetti. June 2018. . I declare that I have no conflicts of interest to make this presentation.. . . Dra. Leticia Cuñetti . Delmonte. June 2018. Chronic pain is a major therapeutic problem in patients with kidney transplant due to the nephrotoxicity of NSAIDs. The Role of Potency in Cannabis Use Outcomes. A joint report from the University of Washington . and Washington State University Workgroup . for the Prevention and Research Sub Committee (PRSC) . October 2020. Jeanette M. Tetrault, MD FACP FASAM. Professor of Medicine. Program Director, Addiction Medicine Fellowship. Associate Director for Education and Training, . Program in Addiction Medicine. Yale School of Medicine. amongst . low-SES users and the arrival of CBD . on . the retail market . . . Dr Frances . Thirlway. , University of York, Sociology Department.  . .  . EMERGING FINDINGS.  . Cannabis was readily available and used alongside . Learning Objectives. Summarise regulatory changes and other issues that need to be considered for the legal use and supply of medicinal cannabis . Discuss the Commonwealth and state specific requirements to prescribe and dispense medicinal cannabis in Australia. Marinol and . Syndros. (synthetic THC Max daily 20mg/16.8mg) and . Cesamet. (THC analog) - anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS), nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. . Jeanette M. Tetrault, MD FACP FASAM. Associate Professor of Medicine. Program Director, Addiction Medicine Fellowship. Associate Director for Education and Training, Program in Addiction Medicine. Yale School of Medicine.